Colorectal Cancer Screening Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Colorectal Cancer Screening Tests Market Report Overview

The colorectal cancer screening tests market size was valued at $1.21 billion in 2023. The colorectal cancer screening tests market will grow at a CAGR of more than 7% from 2023 to 2033. Globally, colorectal cancer is the third most prevalent cancer in men and the second most common cancer in women. Colorectal cancer screening tests are carried out to monitor the bowel health of at-risk individuals, typically the elderly, to be able to detect and treat colorectal cancer promptly.

Colorectal Cancer Screening Tests Market Outlook 2023-2033 ($ Billion)
Colorectal Cancer Screening Tests Market Outlook 2023-2033 ($ Billion)

Buy the Full Report for More Insights on the Colorectal Cancer Screening Tests Market Forecast,
Download a Free Sample Report

The colorectal cancer screening tests market research report explains the market behavior, which will help identify quantitative market trends within the in vitro diagnostics therapeutic area. The report has extensively covered pipeline products and technologies, which will help in identifying companies with the most robust pipeline. This, in turn, will assist in predictive analysis for designing in-licensing and out-licensing strategies. The colorectal cancer screening tests market model also discusses the detailed impact of COVID-19 on the colorectal cancer screening tests market for 2020 and beyond.

Market Size (2023) $1.21 billion
CAGR (2023-2033) >7%
Historic Period 2015-2023
Forecast Period 2023-2033
Key Segments
  • Fecal DNA Test Kits
  • Guaiac Fecal Occult Blood Test (gFOBT) Kits
  • Immunochemical Fecal Occult Blood Test (iFOBT or FIT) Kits
  • Other Colorectal Cancer Screening Tests
Key Regions
  • Asia-Pacific
  • Europe
  • Middle East and Africa
  • North America
  • South and Central America
Key Companies
  • Exact Sciences Corp
  • HemoCue AB
  • Eiken Chemical Co Ltd
  • Sentinel CH. SpA
  • Resonac Corporation
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Colorectal Cancer Screening Tests Market Dynamics

Aging populations and increasing disease awareness mean that CRC screening has become a national priority for many countries. A greater number of eligible inhabitants coupled with the implementation of numerous national screening campaigns means that this in vitro diagnostics market is expected to grow across all regions during the forecast period. The market is also witnessing the release of various new devices, such as fecal DNA testing kits and blood-based assays for CRC screening which is also a major contributing factor to market growth, especially in the US. Additionally, a switch in device usage from gFOBT to FIT testing kits is occurring in most countries and this is also driving an increase in overall market value.

Buy the Full Report for Additional Colorectal Cancer Screening Tests Market Dynamics, Download a Free Sample Report

Colorectal Cancer Screening Tests Market Segments

The key segments in the colorectal cancer screening tests market are Fecal DNA Test Kits, Guaiac Fecal Occult Blood Test (gFOBT) Kits, Immunochemical Fecal Occult Blood Test (iFOBT or FIT) Kits, and Other Colorectal Cancer Screening Tests. In 2023, the Fecal DNA Test Kits segment dominated the market. The segment is anticipated to continue its dominance during the projected period.

Colorectal Cancer Screening Tests Market Analysis by Segments, 2023 (%)
Colorectal Cancer Screening Tests Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Insights into the Colorectal Cancer Screening Tests Market Segments,
Download a Free Sample Report

Colorectal Cancer Screening Tests Market Segmentation by Regions

The key regions in the colorectal cancer screening tests market are Asia-Pacific, Europe, the Middle East and Africa, North America, and South and Central America. In 2023, North America emerged as the leading regional market.

The North American CRC screening market is expected to grow during the forecast period driven by several factors including population growth, aging populations, improved disease awareness, increases in the percentage of asymptomatic, average-risk individuals undergoing screening, and a switch in device usage.

Colorectal Cancer Screening Tests Market Analysis by Regions, 2023 (%)
Colorectal Cancer Screening Tests Market Analysis by Regions, 2023 (%)

Buy the Full Report for More Regional Insights in the Colorectal Cancer Screening Tests Market,
Download A Free Sample Report

Colorectal Cancer Screening Tests Market – Competitive Landscape

The key companies in the colorectal cancer screening tests market are Exact Sciences Corp, HemoCue AB, Eiken Chemical Co Ltd, Sentinel CH. SpA, and Resonac Corporation among others. In 2023, Exact Sciences Corp accounted for the highest colorectal cancer screening tests market share and value.

Colorectal Cancer Screening Tests Market Analysis by Companies, 2023 (%)
Colorectal Cancer Screening Tests Market Analysis by Companies, 2023 (%)

Buy the Full Report for More Company-Wise Insights into the Colorectal Cancer Screening Tests Market,
Download a Free Sample Report

Segments Covered in this Report

Colorectal Cancer Screening Tests Segment Outlook ($ Million, 2015-2033)

  • Fecal DNA Test Kits
  • Guaiac Fecal Occult Blood Test (gFOBT) Kits
  • Immunochemical Fecal Occult Blood Test (iFOBT or FIT) Kits
  • Other Colorectal Cancer Screening Tests

Colorectal Cancer Screening Tests Regional Outlook ($ Million, 2015-2033)

  • Asia-Pacific
  • Europe
  • Middle East and Africa
  • North America
  • South and Central America

Key Inclusions of the market model are –

Currently marketed colorectal cancer screening tests market and evolving competitive landscape –

  • Insightful review of the key industry trends.
  • Annualized total colorectal cancer screening tests market revenue by segment and market outlooks from 2015-2033.
  • Market-level data on units, average selling prices, and market values.

Global, Regional, and Country level market specific insights –

  • Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
  • SWOT analysis for the Colorectal cancer screening tests market.
  • Competitive dynamics insights and trends provided for the colorectal cancer screening tests market.

Understand the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country-specific overview of the healthcare system.
  • Country-specific reimbursement policies.
  • Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Eiken Chemical Co Ltd, Sentinel CH. SpA, Alfresa Pharma Corp, Showa Denko Materials Co Ltd, Danaher Corp, Hemosure Inc, Medline Industries Inc, QuidelOrtho Corp, Sekisui Diagnostics LLC, Epigenomics AG, Exact Sciences Corp, Aerscher Diagnostics LLC, Thermo Fisher Scientific Inc, Boditech Med Inc, McKesson Corp, Propper Manufacturing Co Inc, and others.

Countries covered – United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for

  • CMO executives must have a deep understanding of the colorectal cancer screening tests marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives must understand crucial components of the supply base to make decisions about supplier selection and management.
  • Private equity investors who need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to –

  • Understand the impact of COVID-19 on colorectal cancer screening tests.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving colorectal cancer screening tests.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the colorectal cancer screening tests market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific colorectal cancer screening tests market from 2015-2033.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Eiken Chemical Co Ltd
Sentinel CH. SpA
Alfresa Pharma Corp
Showa Denko Materials Co Ltd
Danaher Corp
Hemosure Inc
Medline Industries Inc
QuidelOrtho Corp
Sekisui Diagnostics LLC
Epigenomics AG
Exact Sciences Corp
Aerscher Diagnostics LLC
Thermo Fisher Scientific Inc
Boditech Med Inc
McKesson Corp
Propper Manufacturing Co Inc
Others

Frequently asked questions

Colorectal Cancer Screening Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 thematic reports
Currency USD
$7,500

Can be used by individual purchaser only

$22,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Colorectal Cancer Screening Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Colorectal Cancer Screening Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 in real time.

  • Access a live Colorectal Cancer Screening Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.